RIGAMONTI, DOROTEA
RIGAMONTI, DOROTEA
DIPARTIMENTO DI SCIENZE FARMACOLOGICHE (attivo dal 01/01/2001 al 27/04/2012)
Adaptation of NS cells growth and differentiation to high-throughput screening-compatible plates
2010 A. Garavaglia, A. Moiana, S. Camnasio, D. Bolognini, R. Papait, D. Rigamonti, E. Cattaneo
Turning REST/NRSF dysfunction in Huntington's disease into a pharmaceutical target
2009 D. Rigamonti, C. Mutti, C. Zuccato, E. Cattaneo, A. Contini
Temozolomide and carmustine cause large-scale heterochromatin reorganization in glioma cells
2009 R. Papait, L. Magrassi, D. Rigamonti, E. Cattaneo
Loss of huntingtin function complemented by small molecules acting as repressor element 1/neuron restrictive silencer element silencer modulators
2007 D. Rigamonti, D. Bolognini, C. Mutti, C. Zuccato, M. Tartari, F. Sola, M. Valenza, A.G. Kazantsev, E. Cattaneo
Protective role of Cop in Rip2/Caspase-1/Caspase-4-mediated HeLa cell death
2006 X. Wang, M. Narayanan, J.M. Bruey, D. Rigamonti, E. Cattaneo, J.C. Reed, R.M. Friedlander
Prevention of cytosolic IAPs degradation: a potential pharmacological target in Huntington's Disease
2005 D. Goffredo, D. Rigamonti, C. Zuccato, M. Tartari, M. Valenza, E. Cattaneo
Progressive loss of BDNF in a mouse model of Huntington's disease and rescue by BDNF delivery
2005 C. Zuccato, D. Liber, C. Ramos, A. Tarditi, D. Rigamonti, M. Tartari, M. Valenza, E. Cattaneo
Dysfunction of the cholesterol biosynthetic pathway in Huntington's disease
2005 M. Valenza, D. Rigamonti, D. Goffredo, C. Zuccato, S. Fenu, L. Jamot, A. Strand, A. Tarditi, B. Woodman, M. Racchi, C. Mariotti, S. Di Donato, A. Corsini, G. Bates, R. Pruss, J.M. Olson, S. Sipione, M. Tartari, E. Cattaneo
From target identification to drug screening assays for neurodegenerative diseases
2005 C. Zuccato, M. Tartari, D. Goffredo, E. Cattaneo, D. Rigamonti
Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes
2003 C. Zuccato, T. Tartari, C. Crotti, D. Goffredo, M. Valenza, L. Conti, T. Cataudella, B.R. Leavitt, M.R. Hayden, T. Timmusk, D. Rigamonti, E. Cattaneo
Calcium-dependent cleavage of endogenous wild-type huntingtin in primary cortical neurons
2002 D. Goffredo, D. Rigamonti, M. Tartari, A. De Micheli, C. Verderio, M. Matteoli, C. Zuccato, E. Cattaneo
Huntingtin’s neuroprotective activity occurs via inhibition of pro-caspase 9 processing
2001 D. Rigamonti, S. Sipione, D. Goffredo, C. Zuccato, E. Fossale, E. Cattaneo
Shc signaling in differentiating neural progenitor cells
2001 L. Conti, S. Sipione, L. Magrassi, L. Bonfanti, D. Rigamonti, V. Pettirossi, M. Peschanski, B. Haddad, P. Pelicci, G. Milanesi, G. Pelicci, E. Cattaneo
Loss of normal huntingtin function: new developments in Huntington's Disease research
2001 E. Cattaneo, D. Rigamonti, D. Goffredo, C. Zuccato, F. Squitieri, S. Sipione
Aberrant amplification of A(2A) receptor signaling in striatal cells expressing mutant huntingtin
2001 K. Varani, D. Rigamonti, S. Sipione, A. Camurri, P. Borea, F. Cattabeni, M. Abbracchio, E. Cattaneo
Gene therapy of experimental brain tumors using neural progenitor cells
2000 S. Benedetti, B. Pirola, B. Pollo, L. Magrassi, M.G. Bruzzone, D. Rigamonti, R. Galli, S. Selleri, F. Di Meco, C. De Fraja, A. Vescovi, E. Cattaneo, G. Finocchiaro
Wild-type huntingtin protects from apoptosis upstream of caspase-3
2000 D. Rigamonti, J.H. Bauer, C. De Fraja, L. Conti, S. Sipione, C. Sciorati, E. Clementi, A. Hackam, M.R. Hayden, Y. Li, J.K. Cooper, C.A. Ross, S. Govoni, C. Vincenz, E. Cattaneo